KRAS and malignant colon neoplasm: For example, in MSS colon cancer, a higher BMI is associated with a decreased mutation frequency of KRAS and PTEN. This is likely due to the obesity-induced cell survival and proliferation pathways (e.g., such as ERK and AKT) that bypass the requirement for mutations in these pathways.